Search
News & Events
New trial aims to nip chronic lung disease in the bud for First Nations kidsWA researchers will use a $1.97 million Medical Research Future Fund grant to develop a strategy for better follow-up of First Nations children after they’ve been hospitalised for respiratory infections, in a bid to halt the slide into more severe lung disease.
News & Events
Fellowship to support research into ways to improve the lung health of people born pretermWal-yan Respiratory Research Centre researcher Ms Denby Evans has been awarded one of four inaugural fellowships supported by the State's Future Health Research and Innovation (FHRI) Fund and Brightspark Foundation, enabling her to further her research into ways to improve the lung health of people
Early intervention in autism is proving a game changer.
Billionaire Stan Perron has made donations to The Kids as part of the Stan Perron Charitable trust totaling $500,000 a year. Read more about his generosity
Create happy, healthy futures for generations of children
News & Events
Illuminate Sundowner 2024Illuminate Awards are a philanthropic initiative - shining a light on child health research to help all kids lead happy, healthy lives.
News & Events
Meet the Researcher: Hannah MooreAfter 20 years at the Institute, Hannah’s career has been a whirlwind of discovery and dedication.
Research
Invasive mould infection in children – advances made or obstacles remaining?Invasive mould infection (IMI) is a major cause of morbidity and mortality in immunocompromised children. Outcomes for paediatric patients with IMI remain poor, due in part to the limitations of available diagnostic tools and therapeutic agents.
Research
Factors Associated With Rare Pediatric Cancer Trial Enrollment: A Report From the Children's Oncology Group Rare Tumors CommitteeOver 90% of US children with cancer are treated at Children's Oncology Group (COG) centers, which seek to maximize enrollment in therapeutic and biobanking studies. Rare cancers have demonstrated lower than expected COG enrollment. We evaluated trends in COG rare cancer enrollment compared to US incidence from Surveillance, Epidemiology, and End Results (SEER) registries, examining the impact of COG therapeutic trials and Project:EveryChild, a cancer biobank/registry.